High uric acid or low uric acid which is better for hemodialysis patients?

Wenyun Wang,Wei Liu,Zhifang Zhao,Yu Zhao,Chengji Zhao

DOI: https://doi.org/10.1080/0886022x.2020.1784227

IF: 3.222

2020-07-30

Renal Failure

Abstract:I have read with great interest the paper entitled 'Low serum uric acid levels increase the risk of all-cause death and cardiovascular death in hemodialysis patients' by Ming et al. [ 1 ]. Uric acid (UA) plays an important role in the elimination of nitrogenous compounds and antioxidant in healthy people. The article included 210 hemodialysis (HD) patients with a mean UA of 532.5 ± 137.4 μmol/L, and showed that with a decrease in serum UA(<420 μmol/L), all-cause mortality (log rank χ 2 = 15.61, p = .000), and cardiovascular (CV) mortality (log rank χ 2 = 14.28, p = .000) increased. Each 100 μmol/L increase in serum UA was associated with lower all-cause mortality with a hazard ratio (HR) of 0.792 (0.645-0.972) and lower CV mortality with an HR of 0.683(0.505-0.924) after adjusting for age, sex, and complications. Compared to the lowest quartile (<420 μmol/L), all-cause mortality [HR 0.351(0.132-0.934), p = .036] and CV mortality [HR 0.112(0.014-0.925), p = .042] were lower in the highest quartile (>644 μmol/L). I pay special attention to the results of this research because it caused me some confusion.

urology & nephrology

What problem does this paper attempt to address?

This paper aims to explore the effects of high and low uric acid levels on hemodialysis patients. Specifically, it attempts to determine whether high or low uric acid levels are more beneficial to survival rate, especially all - cause mortality and cardiovascular mortality, for hemodialysis patients.

The research background points out that uric acid (UA) plays an important role in removing nitrogen - containing compounds and acting as an antioxidant in healthy humans. However, for hemodialysis patients, the relationship between uric acid levels and the risk of death is controversial. This paper cites the results of multiple studies. Some of these studies suggest that high uric acid levels may not increase the risk of cardiovascular events or all - cause death, while other studies indicate that low uric acid levels are associated with a higher risk of death.

Specific to the research results in this paper, the author mentions that in a study of 210 hemodialysis patients, it was found that as the serum uric acid level decreased (<420 μmol/L), both all - cause mortality (chi - square test \(\chi^2 = 15.61\), \(p = 0.000\)) and cardiovascular mortality (chi - square test \(\chi^2 = 14.28\), \(p = 0.000\)) increased. After adjusting for age, gender, and complications, for every 100 μmol/L increase in serum uric acid level, the hazard ratio (HR) for all - cause mortality was 0.792 (95% CI: 0.645 - 0.972), and the hazard ratio for cardiovascular mortality was 0.683 (95% CI: 0.505 - 0.924). Compared with the lowest quartile group (<420 μmol/L), the all - cause mortality and cardiovascular mortality in the highest quartile group (>644 μmol/L) were significantly lower.

The author also points out some confusing points in the study. For example, some indicators not reaching the target values may affect the accuracy of the conclusion, and proposes the view that using uric acid difference (UAD) as the best indicator for evaluating uric acid levels.

In conclusion, this paper attempts to answer the question of whether high or low uric acid levels are more favorable for hemodialysis patients by analyzing the relationship between uric acid levels and survival rate in hemodialysis patients.